Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05920252 · ClinicalTrials.gov registry record · NA

A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide

A NA study of Suicide and Anhedonia, sponsored by Ksana Health.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT05920252 is a NA study of Suicide and Anhedonia that is actively recruiting participants, run by Ksana Health. The registered enrollment target is 78 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05920252, a NA study of Suicide and Anhedonia, is actively recruiting participants, sponsored by Ksana Health.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance among high-risk individuals. This project aims to enhance the effectiveness of the delivery of preventative health care to youth at risk for suicide by developing a comprehensive digital platform that allows practitioners to integrate mobile sensing data and HIPAA-compliant client communication tools into their management of these young people.

Interventions

  • BEHAVIORAL Treatment as Usual (TAU)
  • BEHAVIORAL Vira

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2024-08-14
Est. Completion 2026-12-31
Phase NA

Sponsor

Ksana Health

4 total trials

What the Registry Record Tells You About NCT05920252

The ClinicalTrials.gov registry entry for NCT05920252 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is Ksana Health, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT05920252 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05920252 about?

NCT05920252 is a clinical study titled "A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide". Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psycholo...

What is the current status of trial NCT05920252?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2024-08-14. Estimated completion is 2026-12-31.

What conditions does trial NCT05920252 study?

This clinical trial studies the following conditions: Suicide, Anhedonia, Mental Health Disorder.

What interventions are being tested in trial NCT05920252?

The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Vira (BEHAVIORAL).

Who is sponsoring clinical trial NCT05920252?

This trial is sponsored by Ksana Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05920252 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.